glp 1 study Could GLP-1 Receptor Agonists Help Prevent Infections in People with Diabetes? A Nationwide Says Yes—At Least for the Lungs and Feet #ActAgainstAmputation #DiabeticFoot #GLP1RA Now, new research suggests that

Overall, no increased risk of pancreatitis, pancreatic/hepatocellular/colorectal cancer, aspiration/pneumonia, or diabetic retinopathy is seen in patients on GLP-1 receptor agonist therapies

UHC does step therapy for Wegovy on some plans, requiring phentermine or Contrave first

[DOI] [PMC free article] [PubMed] [Google Scholar] 26.Qiao Q., Ouwens M.J., Grandy S., Johnsson K., Kostev K

For most individuals, treatment may last for several months, depending on their weight loss goals and overall health

However, these compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality

Int J Obes (2016) 40(2):198205